Heart test-maker CardiOx has closed an $8 million series C round of investment that the company plans to use to begin U.S. and European commercialization. The round was led by Michigan-based Lifeline Ventures, a new investor in Columbus, Ohio-based CardiOx, and included contributions from existing investors Early Stage Partners, Glengary and Reservoir Partners, CardiOx CEO […]
CardiOx is hoping to close a $3.5 million series C round of investment that would go toward commercializing its noninvasive test for holes in the heart. The Columbus, Ohio-area company is also looking to obtain European and U.S. regulatory clearance by the end of the year, with the European Union’s CE Mark expected to come […]
CardiOx Corp., which is developing a noninvasive method for detecting holes in the heart, has raised about $650,000 of an anticipated $2 million in investment funding.
Ohio Third Frontier commissioners made a slew of biomedical grants under two programs today. Recommended for more than $4.9 million under the Ohio Third Frontier Biomedical Program: — CardioX Corp., Dublin, in collaboration with Nottingham-Spirk Design Associates in Cleveland and QTest Labs in Columbus, was awarded $986,373 to finalize designs and clinical protocols for a […]
CardioX, which is developing technology to detect heart defects, recently completed about $780,000 in addition fund-raising -- bringing its private equity funding for 2009 to just more than $1 million, according to filings with the Securities and Exchange Commission.
